Literature DB >> 9000541

LPS pretreatment reprograms macrophage LPS-stimulated TNF and IL-1 release without protein tyrosine kinase activation.

M A West1, T Bennet, S C Seatter, L Clair, J Bellingham.   

Abstract

Pretreatment of macrophages with low-dose endotoxin (LPSp) profoundly alters cytokine release in response to subsequent LPSa activation. These qualitative and quantitative alterations in cytokine release have been termed macrophage reprogramming. Macrophage activation by LPS is thought to occur via a mechanism involving an early protein tyrosine kinase (PTK) phosphorylation step. PTK inhibition with genistein or herbimycin A blocks LPSa-stimulated secretion of tumor necrosis factor (TNF) and interleukin-1 (IL-1). In this study we investigated whether a PTK pathway participates in LPSp pretreatment reprogramming. We show that LPSp pretreatment inhibited TNF and augmented IL-1 release in response to subsequent LPSa stimulation. Blockade of PTK activation pathways during the interval when macrophages were exposed to LPSp prevented mitogen-activated protein kinase phosphorylation, as well as LPSp-stimulated release of TNF and IL-1, but did not block LPSp reprogramming effects. We conclude that LPSp pretreatment reprogramming of macrophage cytokine production does not require PTK activation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9000541     DOI: 10.1002/jlb.61.1.88

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  8 in total

1.  Candida albicans-derived beta-1,2-linked mannooligosaccharides induce desensitization of macrophages.

Authors:  T Jouault; C Fradin; P A Trinel; D Poulain
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Up-regulation of growth factor independence 1 in endotoxin tolerant macrophages with low secretion of TNF-alpha and IL-6.

Authors:  Min-Fang Zhu; Jing Zhang; Jie-Ming Qu; Hui-Jun Zhang; Shuang-Cheng Zhou; Sheng-Fu Dong; Hong-Ni Jiang; Hanssa Summah
Journal:  Inflamm Res       Date:  2010-04-17       Impact factor: 4.575

3.  Immunomodulatory Activity of Sulfonamide Chalcone Compounds in Mice Infected with Filarial Parasite, Brugia malayi.

Authors:  Priyanka Bhoj; Namdev Togre; Sandeep Bahekar; Kalyan Goswami; Hemant Chandak; Mandakini Patil
Journal:  Indian J Clin Biochem       Date:  2018-01-24

Review 4.  Macrophages as a therapeutic target to promote diabetic wound healing.

Authors:  Maryam Sharifiaghdam; Elnaz Shaabani; Reza Faridi-Majidi; Stefaan C De Smedt; Kevin Braeckmans; Juan C Fraire
Journal:  Mol Ther       Date:  2022-08-02       Impact factor: 12.910

5.  TLR4 mediates LPS-induced HO-1 expression in mouse liver: role of TNF-alpha and IL-1beta.

Authors:  Yong Song; Yi Shi; Li-Hua Ao; Alden H Harken; Xian-Zhong Meng
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

Review 6.  Macrophage Modification Strategies for Efficient Cell Therapy.

Authors:  Anastasiya S Poltavets; Polina A Vishnyakova; Andrey V Elchaninov; Gennady T Sukhikh; Timur Kh Fatkhudinov
Journal:  Cells       Date:  2020-06-24       Impact factor: 6.600

7.  Fh15 Blocks the Lipopolysaccharide-Induced Cytokine Storm While Modulating Peritoneal Macrophage Migration and CD38 Expression within Spleen Macrophages in a Mouse Model of Septic Shock.

Authors:  Marcos J Ramos-Benitez; Caleb Ruiz-Jimenez; Jose J Rosado-Franco; Willy D Ramos-Pérez; Loyda B Mendez; Antonio Osuna; Ana M Espino
Journal:  mSphere       Date:  2018-12-19       Impact factor: 4.389

8.  Manifestation of lipopolysaccharide-induced tolerance in neuro-glial primary cultures of the rat afferent somatosensory system.

Authors:  Franz Nürnberger; Stephan Leisengang; Daniela Ott; Jolanta Murgott; Rüdiger Gerstberger; Christoph Rummel; Joachim Roth
Journal:  Inflamm Res       Date:  2021-02-13       Impact factor: 4.575

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.